Global Non-Invasive Prenatal Testing Market Size, Share, Business Opportunities, Challenges, Drivers and Restraint Research Report by 2027

Posted April 19, 2022 by pratam

The global Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research
The latest market evaluation report on the Non-Invasive Prenatal Testing market explores how the Non-Invasive Prenatal Testing market will continue to expand for the forecast period 2020 - 2027. The study further serves as a unique research for stakeholders, product owners, and field marketing executives looking for actionable data and unique resource on market size, share, and growth. The market intelligence report gives business evangelists an authority to review the major trends, opportunities, and challenges expected to shape the future of the industry during the estimated period. Importantly, the study not only helps spot the major vendors but also their winning strategies. The real-time

Additionally, the report also gives an insight into product portfolios, costs, sales, production capacities, and market players. Raw materials, demand analysis, product flow, and distribution channels have been studied and surveyed extensively in this research report. The key growth trends and opportunities are offered through a thorough investigation and examination of the market. A detailed course of development is offered in the report along with insights into businesses connected with it, which include firms, industries, organizations, vendors, and local manufacturers.

Get a sample of the report :

Despite NIPT being accessible in growing amounts of regions, there is a major commercial push expected to assist consumer expansion in the projected years. NIPT was confirmed through similarities with standard prenatal aneuploidy screening and found to be a beneficial screening procedure with keen sensitivity and specificity. Increasing popularity among pregnant women as an alternative to amniocentesis and awareness of prenatal genetic problems drives non-invasive prenatal testing.

Annually, an average USD 4,879.0 is expended on child healthcare in the U.S., which is expected to benefit the non-invasive pregnancy testing sector in North America, according to work conducted by the Health Expense Institute. Due to the increasing focus on minimally invasive diagnostic procedures and preference for early detection of illness, the recognition among citizens and expanding healthcare services, Asia Pacific is projected to grow significantly in the global market for non-invasive prenatal research.

The NGS technology, along with cfDNA research, has paved the way for the identification of chromosomal aberrations with growing efficiency and lowering expense. The high-risk testing industry is crowded, and continued rivalry is likely to result in substantial declines in the retail sales price of such tests. The prevalence of such studies can be improved with reduced costs in the market for reproductive genetics. The creation of new technology for NIPT is gradually increasing due to the rising awareness of the advantages of non-invasive methods.

The trisomy application is the major contributor to the Non-Invasive Prenatal Testing Market. The trisomy application of the North America region is the major shareholder of the market and held around 45.1% of the market in the year 2019, owing to the high incidence of genetic disorders correlated with trisomy’s, such as Patau syndrome, Down syndrome, and Edward syndrome.

North America dominated the market for Non-Invasive Prenatal Testing in 2019 due to the availability of technologically advanced healthcare research system, the region's production of WGS. The North America region held approximately 48.8% of the market, followed by Europe, which contains around 25.4% market in the year 2019.

Key participants include Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI, and Natera Inc., among others.

For the purpose of this report, Emergen Research has segmented into the global Non-Invasive Prenatal Testing market based on the method, end-use, application, and region:

Method Outlook (Revenue, USD Billion; 2017-2027)
Ultrasound Detection
Biochemical Screening Tests
Cell-free DNA in Maternal Plasma Tests
End-Use Outlook (Revenue, USD Billion; 2017-2027)
Diagnostic Laboratories
Research Centers
Application Outlook (Revenue, USD Billion; 2017-2027)
Microdeletion Syndrome
Request a discount on the report :

Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
Rest of Europe
Asia Pacific
South Korea
Rest of APAC
Saudi Arabia
Rest of MEA
Latin America
Rest of LATAM
Key Objectives of the Report:

Analysis and estimation of the Non-Invasive Prenatal Testing market size and share for the projected period of 2020-2027

Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Non-Invasive Prenatal Testing market

Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments

Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Read More:

Related reports:

Face MaskMarket:

Nucleic Acid Isolation and Purification Market:

Non-Invasive Prenatal Testing Market:

Joint Reconstruction DevicesMarket:

Blockchain in Healthcare: Https://

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalnt in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkdIn | Twitter | Blogs
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By pavii
Phone 09153278965
Business Address pune
Country India
Categories Health
Tags growth , shape
Last Updated April 19, 2022